In an analysis comparing ifosfamide and topotecan plus cyclophosphamide, the investigators showed that the length of time patients remained free of progression or second malignancies after study ...

Patients who have relapsed or individuals who do not respond to first-line chemotherapy can be treated with topotecan. Phase II and III studies have confirmed the efficacy of topotecan as second ...